HSK21542 + Placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Postoperative Analgesia
Conditions
Postoperative Analgesia
Trial Timeline
Mar 24, 2021 → Sep 30, 2021
NCT ID
NCT04738357About HSK21542 + Placebo
HSK21542 + Placebo is a phase 3 stage product being developed by Haisco Pharmaceutical Group for Postoperative Analgesia. The current trial status is completed. This product is registered under clinical trial identifier NCT04738357. Target conditions include Postoperative Analgesia.
What happened to similar drugs?
20 of 20 similar drugs in Postoperative Analgesia were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05135390 | Phase 3 | Completed |
| NCT04999787 | Phase 2 | Completed |
| NCT04738357 | Phase 3 | Completed |
| NCT04110886 | Phase 1 | Completed |
Competing Products
20 competing products in Postoperative Analgesia